Latest filing published 30 Dec 2015 for Iovance Biotherapeutics, INC., €58k.
Insider track record
No signal scores available.
James G. Bender: trading record in brief
James G. Bender is a declared insider at 2 companies; the most frequent names are ImmunoCellular Therapeutics, Ltd. and Iovance Biotherapeutics, Inc. Between 31 May 2012 and 30 September 2015, the trades on record add up to 16 filings.
The open-market record consists of 12 sales worth €94k, with no purchase. Outside the open market, there are 3 share grants and 1 option exercise.
The latest filing, published on 30 December 2015, reports a share grant of €58k in Iovance Biotherapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James G. Bender
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,274 shares@ US$5.76Common StockSEC:0001250853-15-000108:0
- 100,000 shares0Common StockSEC:0001250853-14-000015:0
- 20,000 shares@ US$0.95Common StockSEC:0001181431-13-047124:0
- 6,376 shares@ US$2.98Common StockSEC:0001181431-13-047124:1
- 5,000 shares@ US$2.84Common StockSEC:0001181431-13-047124:2
- 3,303 shares@ US$2.85Common StockSEC:0001181431-13-047124:3
- 5,000 shares@ US$2.88Common StockSEC:0001181431-13-047124:4
- 900 shares@ US$3.00Common StockSEC:0001181431-13-047124:5
- 1,500 shares@ US$3.59Common StockSEC:0001250853-12-000057:0
- 4,900 shares@ US$3.60Common StockSEC:0001250853-12-000057:1
- 600 shares@ US$3.61Common StockSEC:0001250853-12-000057:2
- 6,800 shares@ US$3.92Common StockSEC:0001250853-12-000056:0
- 200 shares@ US$3.94Common StockSEC:0001250853-12-000056:1
13 of 13 declarations
